Evaluating a 45 Day Rehab: A Professional’s Guide

The 90-Day Benchmark, Read Honestly

The 90-day number you keep seeing on rehab websites did not come from marketing. It comes from NIDA’s research-based guide, which states plainly that participation in residential or outpatient treatment for less than 90 days is generally of limited effectiveness, and that longer durations are recommended for maintaining positive outcomes ¹³. That is a real finding, and dismissing it would be dishonest.

So would treating it as the only finding. The same body of research also acknowledges that individuals progress at different rates and that treatment length should be adjusted to clinical needs. And one peer-reviewed continuing care review reported something that rarely makes it into the brochure: patients whose average residential stay was 90 days showed significantly less improvement in ASI alcohol composite scores than patients averaging 15 to 30 or 31 to 45 days ². That result does not overturn the 90-day guidance. It complicates any simple “longer is always better” reading of it.

What National Length-of-Stay Data Tells You

If you want to know whether 45 days is a mainstream choice or a fringe one, the SAMHSA Treatment Episode Data Set gives you the reference points. Among patients who completed treatment in 2019, the median length of stay was 79 days for long-term residential and 25 days for short-term residential ³. A 45-day program sits between those two medians, closer to the middle of the national distribution than to either end.

That placement matters for how you should read a program’s brochure. Forty-five days is not a discount version of 90 days, and it is not an extended version of a 28-day model. It is a distinct clinical window that lets a program absorb medically supervised withdrawal, get you stable, and then spend meaningful time on the therapeutic work that actually predicts what happens after you leave.

What the TEDS data cannot tell you is whether a specific 45-day program is designed to use that window well. Two facilities can both quote 45 days and deliver very different things: one front-loading detox and calling the rest supportive rest, another spending week two onward on individual therapy, co-occurring diagnosis, family sessions, and a written continuing care plan. Ask which one you are being sold.

Detox Is Not Rehab: Separating the Two Inside 45 Days

One of the fastest ways to misread a 45-day program is to assume the whole stay is rehabilitation. It is not. SAMHSA’s TIP 45 puts the general rule for residential detox and short-term treatment at 7 to 30 days ⁵, and detox itself typically occupies the front end of that window, sometimes just the first week to ten days depending on your substance, dosage, and medical history.

That means a well-designed 45-day stay gives you something a 28-day program cannot: two to five additional weeks of actual therapeutic work after your body has stabilized. That is when individual counseling starts to land, when co-occurring anxiety or depression becomes assessable without the noise of acute withdrawal, and when discharge planning stops being theoretical.

When you interview admissions, ask them to draw the line for you. Which days are medically supervised withdrawal? Which days are stabilization? On what day does the therapeutic curriculum actually begin, and how many hours per day of it are you getting? If they cannot answer that clearly, the number 45 on their website is a marketing figure, not a clinical plan.

Severity, Co-Occurring Conditions, and Medical Complexity

Clinical fit is where 45-day programs either earn their length or waste it. The first question is severity. A daily drinker with a decade of high-tolerance use and elevated liver enzymes needs a different opening week than someone whose use escalated over the last eighteen months around a divorce. Both may benefit from 45 days. Only one may safely start therapeutic work in week one.

Co-occurring conditions raise the stakes further. If you carry a diagnosis of depression, generalized anxiety, ADHD, PTSD, or bipolar II, or if you suspect one has been sitting underneath your drinking for years, the residential episode has to do double duty. The research on this is direct: for patients with co-occurring mental health disorders, receiving at least 12 weeks of outpatient mental health treatment after discharge was associated with lower substance use at six months ¹. That finding presumes the residential team accurately diagnosed the co-occurring condition in the first place and handed you off to a clinician who can continue it. A program that treats your anxiety as “withdrawal-related” and never revisits it is not doing dual diagnosis work; it is doing addiction treatment with a mental health garnish.

Medical complexity is the third variable. Prior seizures, benzodiazepine dependence, opioid use with cardiac history, uncontrolled hypertension, or any pattern that has already sent you to an emergency room changes what week one has to look like. Ask whether the facility has 24-hour nursing, on-site or on-call physician coverage for medically supervised withdrawal, and the ability to run medication-assisted treatment when clinically indicated. If the answer is vague, the 45 days on offer are shorter than they appear.

Questions to Ask the Medical Director

You are not being difficult by asking to speak with the medical director before admission. You are doing what any clinically literate professional should do. Keep the call focused.

• Ask who conducts the initial psychiatric evaluation, when it happens, and whether it is repeated after withdrawal clears. A first-week assessment done while you are still symptomatic will miss things a week-three assessment will catch.
• Ask how co-occurring diagnoses are documented, who owns medication decisions during the stay, and how those decisions are communicated to the outpatient psychiatrist who will inherit them.
• Ask for the actual daily schedule during the therapeutic phase, not the marketing summary. How many hours of individual therapy per week? How many of group? What modalities: CBT, motivational enhancement, trauma-focused work? Who runs family sessions and when?
• Ask what would trigger a recommendation to extend beyond 45 days, and what the criteria are for stepping down to IOP earlier.

A medical director who can answer both without hesitation is running a program that treats length as a clinical decision. One who cannot is running a fixed container and hoping you fit.

42 CFR Part 2 and HIPAA: What Each Actually Does

Two different federal frameworks govern what a rehab can say about you, and confusing them is how people get burned. HIPAA covers protected health information across the healthcare system in general. 42 CFR Part 2 sits on top of that with stricter rules built specifically for substance use disorder records held by federally assisted SUD programs. The Part 2 regulations prohibit disclosure of records or information that would identify a person as having been diagnosed, treated, or referred for treatment for a SUD, except under specified conditions ¹¹. In plain terms: your presence at an SUD‑specific facility is itself protected information, not just your chart.

The practical implication is that a Part 2 program cannot confirm you are a patient to your law firm’s HR department, your medical board, or your spouse’s attorney unless you have signed a valid consent or a court order compels it. Records are also barred from use in most civil, criminal, administrative, or legislative proceedings without additional authorization ¹⁰. HIPAA alone does not give you that second layer. When you evaluate a 45‑day program, ask directly whether it is a Part 2 program and how staff are trained on the distinction. If the answer is a shrug, that is your answer.

Single Consent, Redisclosure, and Employer Communications

The 2026 final rule changed one thing you should understand before you sign anything. A single patient consent can now authorize all future uses and disclosures of your SUD records for treatment, payment, and health care operations, rather than requiring a separate form for each recipient ⁹. That is a coordination win for clinicians who need to talk to your outpatient psychiatrist and your insurer. It is also a document you should read slowly, because “all future uses” is a wide door.

Redisclosure is the other point where professionals get hurt. Once information leaves a Part 2 program, the prohibition on redisclosing anything that would identify you as having been diagnosed, treated, or referred for SUD travels with it ¹¹. That protection matters most when your employer, EAP, or licensing body is in the loop. Before you sign any consent naming an employer contact, insist on scope limits in writing: which specific person, what specific information (treatment dates and return‑to‑work clearance, not clinical detail), and a defined expiration date. A program that resists narrowing that language is telling you how it will operate later.

The 3-6 Month Window That Makes 45 Days Work

Day 46 is the day your program’s real quality shows up. The residential episode ends, and what waits on the other side either extends the work or lets it evaporate. The peer-reviewed continuing care literature is direct about the shape of that window: robust recovery after a residential episode typically requires 3 to 6 months of structured continuing care, not a few follow-up calls ². That is the planning horizon you should be negotiating with an admissions team, not the 45 days on their landing page.

Inside that window, the intensity matters as much as the calendar. For patients with co-occurring conditions, receiving at least 12 weeks of outpatient mental health treatment post-discharge was associated with lower substance use at six months ¹. And SAMHSA’s own data situates the outpatient phase: the median length of stay for adults who complete intensive outpatient treatment is 81 days ⁴. Stack those together and the picture is clear. Forty-five days residential plus roughly three months of IOP plus continued mental health treatment is not an aspirational plan. It is the mainstream clinical shape of what tends to work.

Ask your program to draw that arc for you on paper before you admit.

IOP Step-Down and Discharge Planning You Can Verify

Discharge planning is where good 45-day programs separate themselves from adequate ones, and you can test the difference by asking for artifacts, not assurances. A serious program will name the intensive outpatient provider in your home city by the end of your second week, coordinate an intake appointment before you leave, and transmit a clinical handoff document with your consent so the receiving team is not starting from a blank page.

Ask to see the template of the discharge plan. It should include:

• The specific IOP provider and start date
• The outpatient psychiatrist inheriting any medication decisions
• The frequency of individual therapy sessions and for how many weeks
• The recovery peer supports built in
• A documented relapse response plan naming who you call and in what order

Ask what happens if the IOP has a waitlist. A program that has never thought about that gap is a program that will let you fall into it.

One more question worth asking: what percentage of your alumni are still engaged in outpatient care at 90 days post-discharge, and how do you know? A program that tracks this is running continuing care as clinical work, not as a mailing list.

Tech-Enabled Monitoring as Clinical Decision Support

Wearables and mHealth tools have moved from novelty to legitimate clinical decision support, and for a 45-day program handing you off to outpatient care, they can quietly extend the sightline. Transdermal alcohol sensors, heart rate variability, sleep patterns, and smartphone-based ecological momentary assessment give clinicians objective signals about stress, sleep debt, and physiological markers of relapse risk that self-report alone tends to blur ⁶. A systematic review of mHealth interventions for substance use found that most of the studies examined reported at least one statistically significant effect on reduced craving or substance use, with generally high acceptability ⁸. That is meaningful, not miraculous.

The limitations are meaningful too. The wearables literature flags real concerns about user burden, small sample sizes in the outcome studies, and data privacy questions that get sharper when the wearer’s day job involves a bar admission, a medical license, or a board seat ⁷. Before you consent, ask who sees the data, where it is stored, whether it flows into your Part 2 record or sits in a separate vendor system, and what happens to it after discharge. If a program treats monitoring as a marketing bullet rather than a supervised clinical input with documented boundaries, that is your signal to slow down.

ADA and Rehabilitation Act Protections While You’re Away

The fear of professional consequences is not paranoia. It is the single most common reason capable men delay treatment past the point where 45 days would have been enough. So it matters that federal law is more protective than the average HR handbook suggests. Under the ADA and the Rehabilitation Act, employers generally may not deny a job to or fire a qualified person because that person is in treatment or in recovery from a substance use disorder, unless the disorder would prevent safe and competent performance of the essential job functions ¹⁵. Being in treatment is not, by itself, a firing offense.

The protections have real edges you should understand, not gloss over. Current illegal drug use is treated differently from alcohol use and from a history of drug use, and safety-sensitive roles carry additional standards. Licensure and fitness-for-duty rules in medicine, law, aviation, and finance layer their own requirements on top of federal statutes. What the ADA reliably gives you is protection against being discriminated against for the fact of seeking treatment, and confidentiality protections around medical information your employer receives during any accommodation process ¹⁵. Before you take leave, have a plain conversation with an employment attorney about how these protections apply to your specific role and jurisdiction.

The Return-to-Work Plan You Should Have in Hand

A discharge summary is not a return-to-work plan. The Department of Labor’s Recovery-Ready Workplace Toolkit is direct about this: employers should plan for the return to work following SUD treatment, providing needed reasonable accommodations and workplace supports ¹². That planning is your leverage. If your program treats reintegration as your problem to solve alone, they are undersizing what a 45-day episode is supposed to produce.

What you should walk out with, in writing:

• A return-to-work letter with clearance dates and any medical restrictions, drafted so it discloses only what your employer legitimately needs and nothing more
• A proposed schedule for the first four to six weeks that accounts for IOP attendance
• A written list of reasonable accommodations you plan to request, such as flexible hours for outpatient sessions, an adjusted travel schedule during early recovery, or a modified on-call rotation
• A communication script for what you say to colleagues who ask where you were

Ask your program’s discharge planner who at the facility has actually coordinated with employers before, and how they handle the boundary between clinical information and workplace-appropriate information. If an EAP or occupational health office is involved, the same 42 CFR Part 2 consent discipline from earlier applies: narrow the scope, name the recipient, set an expiration. You are not being difficult. You are protecting the career you took 45 days off to preserve.